PILA — Pila Pharma AB Cashflow Statement
0.000.00%
- SEK63.88m
- SEK47.99m
- SEK1.13m
Annual cashflow statement for Pila Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Interim Report | PRESS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.2 | -26.8 | -9.93 | -11.2 | -16.9 |
| Non-Cash Items | 7.94 | 17.9 | 4.57 | 4.16 | 7.28 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.093 | -0.216 | 0.502 | -0.739 | 0.402 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -9.36 | -9.09 | -4.85 | -7.82 | -9.19 |
| Capital Expenditures | 0 | 0 | 0 | 0 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | 0 | 0 | 0 | — |
| Financing Cash Flow Items | -7.92 | -17.9 | -3.5 | -3.08 | -8.75 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 35.7 | -11.9 | 3.56 | 6.76 | 20.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 26.3 | -21 | -1.29 | -1.06 | 11 |